Loomis, Sayles & Company
PCRX icon

Loomis, Sayles & Company’s Pacira BioSciences PCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-412,325
Closed -$11.8M 733
2024
Q2
$11.8M Buy
412,325
+33,692
+9% +$964K 0.02% 329
2024
Q1
$11.1M Buy
378,633
+51,841
+16% +$1.51M 0.02% 341
2023
Q4
$11M Sell
326,792
-48,188
-13% -$1.63M 0.02% 322
2023
Q3
$11.5M Buy
374,980
+34,811
+10% +$1.07M 0.02% 317
2023
Q2
$13.6M Buy
340,169
+66,353
+24% +$2.66M 0.02% 298
2023
Q1
$11.2M Sell
273,816
-1,198,102
-81% -$48.9M 0.02% 317
2022
Q4
$56.8M Buy
1,471,918
+33,177
+2% +$1.28M 0.11% 95
2022
Q3
$76.5M Buy
1,438,741
+152,912
+12% +$8.13M 0.16% 75
2022
Q2
$75M Sell
1,285,829
-7,871
-0.6% -$459K 0.14% 74
2022
Q1
$98.7M Buy
1,293,700
+102,986
+9% +$7.86M 0.13% 66
2021
Q4
$71.6M Buy
1,190,714
+38,867
+3% +$2.34M 0.09% 103
2021
Q3
$64.5M Buy
1,151,847
+25,648
+2% +$1.44M 0.08% 109
2021
Q2
$68.3M Sell
1,126,199
-6,384
-0.6% -$387K 0.08% 105
2021
Q1
$79.4M Sell
1,132,583
-1,770
-0.2% -$124K 0.1% 86
2020
Q4
$67.9M Buy
1,134,353
+292,253
+35% +$17.5M 0.09% 92
2020
Q3
$50.6M Buy
842,100
+15,868
+2% +$954K 0.07% 108
2020
Q2
$43.4M Buy
826,232
+71,236
+9% +$3.74M 0.07% 108
2020
Q1
$25.3M Buy
754,996
+230,403
+44% +$7.73M 0.05% 136
2019
Q4
$23.8M Sell
524,593
-862
-0.2% -$39K 0.04% 187
2019
Q3
$20M Buy
+525,455
New +$20M 0.04% 211
2016
Q4
Sell
-62
Closed -$2K 1084
2016
Q3
$2K Hold
62
﹤0.01% 967
2016
Q2
$2K Sell
62
-49
-44% -$1.58K ﹤0.01% 947
2016
Q1
$6K Buy
111
+74
+200% +$4K ﹤0.01% 921
2015
Q4
$3K Buy
+37
New +$3K ﹤0.01% 967
2014
Q4
Sell
-140,309
Closed -$13.6M 751
2014
Q3
$13.6M Sell
140,309
-38,922
-22% -$3.77M 0.04% 432
2014
Q2
$16.5M Sell
179,231
-63,285
-26% -$5.81M 0.05% 408
2014
Q1
$17M Sell
242,516
-30,899
-11% -$2.16M 0.05% 407
2013
Q4
$15.7M Sell
273,415
-125,669
-31% -$7.22M 0.05% 421
2013
Q3
$19.2M Sell
399,084
-85,752
-18% -$4.12M 0.06% 338
2013
Q2
$14.1K Buy
+484,836
New +$14.1K 0.05% 403